ATE513032T1 - Aufgereinigte bakterielle minizellen - Google Patents

Aufgereinigte bakterielle minizellen

Info

Publication number
ATE513032T1
ATE513032T1 AT08101712T AT08101712T ATE513032T1 AT E513032 T1 ATE513032 T1 AT E513032T1 AT 08101712 T AT08101712 T AT 08101712T AT 08101712 T AT08101712 T AT 08101712T AT E513032 T1 ATE513032 T1 AT E513032T1
Authority
AT
Austria
Prior art keywords
minicells
provides
minicell preparations
purified minicell
parent bacterial
Prior art date
Application number
AT08101712T
Other languages
English (en)
Inventor
Himanshu Brahmbhatt
Jennifer Macdiarmid
Original Assignee
Engeneic Molecular Delivery Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Engeneic Molecular Delivery Pty Ltd filed Critical Engeneic Molecular Delivery Pty Ltd
Application granted granted Critical
Publication of ATE513032T1 publication Critical patent/ATE513032T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02Separating microorganisms from their culture media
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT08101712T 2003-06-24 2004-06-23 Aufgereinigte bakterielle minizellen ATE513032T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/602,021 US7611885B2 (en) 2003-06-24 2003-06-24 Pharmaceutically compatible method for purifying intact bacterial minicells

Publications (1)

Publication Number Publication Date
ATE513032T1 true ATE513032T1 (de) 2011-07-15

Family

ID=33539477

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04743793T ATE461269T1 (de) 2003-06-24 2004-06-23 Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen
AT08101712T ATE513032T1 (de) 2003-06-24 2004-06-23 Aufgereinigte bakterielle minizellen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04743793T ATE461269T1 (de) 2003-06-24 2004-06-23 Pharmazeutisch verträgliches verfahren zur reinigung intakter bakterienminizellen

Country Status (19)

Country Link
US (4) US7611885B2 (de)
EP (3) EP1636344B1 (de)
JP (1) JP4834544B2 (de)
CN (2) CN1809629B (de)
AT (2) ATE461269T1 (de)
AU (2) AU2004249970B2 (de)
CA (2) CA2530055C (de)
CY (1) CY1118218T1 (de)
DE (1) DE602004026051D1 (de)
DK (3) DK1947171T3 (de)
ES (3) ES2342830T3 (de)
HK (3) HK1089207A1 (de)
HU (1) HUE030642T2 (de)
MX (1) MXPA05013620A (de)
NZ (1) NZ544653A (de)
PL (2) PL1947171T3 (de)
PT (2) PT1947171E (de)
SI (1) SI2333044T1 (de)
WO (1) WO2004113507A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2302063B1 (de) * 2001-10-15 2016-05-04 EnGeneIC Molecular Delivery Pty Ltd. Intakte Minizellen als Vektoren für DNA-Transfer und Gentherapie in vitro und in vivo
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
CA2549840C (en) 2003-12-09 2012-03-20 Engeneic Molecular Delivery Pty Ltd. Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
WO2005079854A1 (en) 2004-02-02 2005-09-01 Engeneic Molecular Delivery Pty Ltd. Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
US8772013B2 (en) * 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
SI2386640T1 (sl) 2004-08-26 2015-06-30 Engeneic Molecular Delivery Pty Ltd Dostava funkcionalnih nukleinskih kislin celicam sesalcev preko bakterijsko izvirajočih, intaktnih minicelic
US9878043B2 (en) 2006-06-23 2018-01-30 Engeneic Molecular Delivery Pty Ltd Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
DK2865755T3 (en) 2007-03-30 2017-05-15 Engeneic Molecular Delivery Pty Ltd BACTERIAL DERIVATIVE INTACT MINICELLS WITH REGULATORY RNA
CA2729545C (en) 2008-06-25 2019-07-09 Vaxiion Therapeutics, Inc. Regulated genetic suicide mechanism compositions and methods
CN102656186A (zh) 2008-07-17 2012-09-05 纽崔佩普有限公司 治疗剂
JP5816164B2 (ja) 2009-05-07 2015-11-18 ビオメリュー・インコーポレイテッド 抗生物質耐性測定方法
US20120142089A1 (en) * 2010-12-01 2012-06-07 Samsung Electronics Co., Ltd. Method of separating target cell in biological sample
US9624474B2 (en) * 2010-12-01 2017-04-18 Samsung Electronics Co, Ltd. Method of separating target cell in biological sample
US9844598B2 (en) * 2011-12-13 2017-12-19 Engeneic Molecular Delivery Pty Ltd Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
WO2013110120A1 (en) 2012-01-24 2013-08-01 Inter-K Pty Limited Peptide agents for cancer therapy
KR102433719B1 (ko) 2013-10-04 2022-08-17 엔진아이씨 몰레큘러 딜리버리 피티와이 리미티드 약물 로딩된, 이중특이성 리간드-표적화된 미니세포 및 인터페론 감마에 의한 복합 종양 치료
EP3200765A4 (de) 2014-10-03 2018-05-30 EnGeneIC Molecular Delivery Pty Ltd Verbessertes laden von intakten, bakteriell abgeleiteten vesikeln mit kleinen molekülverbindungen
WO2017024059A1 (en) 2015-08-04 2017-02-09 Vaxiion Therapeutics, Llc Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
CN110022905B (zh) 2016-10-06 2024-02-06 安吉尼科分子传输公司 用于递送核酸佐剂的细菌小细胞和使用其的方法
EP3826654A4 (de) 2018-07-23 2022-07-06 EnGeneIC Molecular Delivery Pty Ltd Zusammensetzungen mit aus bakterien abgeleiteten minizellen und verfahren zur verwendung davon
WO2021257788A1 (en) * 2020-06-17 2021-12-23 Flagship Pioneering Innovations Vi, Llc Methods for manufacturing adas
CN113186100B (zh) * 2021-05-11 2022-10-04 中国科学院青岛生物能源与过程研究所 一种富集污水微生物以用于单细胞精度表型测量和分选的试剂盒及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311797A (en) 1979-09-18 1982-01-19 University Of Saskatchewan Anucleated live E. coli vaccine
CN1375004A (zh) 1999-04-21 2002-10-16 惠氏公司 抑制多核苷酸序列的功能的方法和组合物
AU2001294520A1 (en) * 2000-08-21 2002-03-04 Clonex Development, Inc. Methods and compositions for increasing protein yield from a cell culture
WO2002072759A2 (en) 2001-03-07 2002-09-19 Children's Medical Center Corporation Method to screen peptide display libraries using minicell display
US7011946B2 (en) * 2001-05-22 2006-03-14 Trustees Of Tufts College In vivo assay for identification of antimicrobial agents
US20030194798A1 (en) 2001-05-24 2003-10-16 Surber Mark W. Minicell compositions and methods
EP2302063B1 (de) 2001-10-15 2016-05-04 EnGeneIC Molecular Delivery Pty Ltd. Intakte Minizellen als Vektoren für DNA-Transfer und Gentherapie in vitro und in vivo
CA2517027A1 (en) 2002-02-25 2003-09-04 Vaxiion Therapeutics, Inc. Minicell compositions and methods
US7611885B2 (en) 2003-06-24 2009-11-03 Engeneic Molecular Delivery Pty, Ltd. Pharmaceutically compatible method for purifying intact bacterial minicells
CA2549840C (en) 2003-12-09 2012-03-20 Engeneic Molecular Delivery Pty Ltd. Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
US8772013B2 (en) 2004-02-02 2014-07-08 Engeneic Molecular Delivery Pty Ltd Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
SI2386640T1 (sl) 2004-08-26 2015-06-30 Engeneic Molecular Delivery Pty Ltd Dostava funkcionalnih nukleinskih kislin celicam sesalcev preko bakterijsko izvirajočih, intaktnih minicelic
KR100967868B1 (ko) 2004-12-17 2010-07-05 베쓰 이스라엘 디코니스 메디칼 센터 박테리아 매개 유전자 침묵을 위한 조성물 및 이것을이용하는 방법
US9878043B2 (en) 2006-06-23 2018-01-30 Engeneic Molecular Delivery Pty Ltd Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

Also Published As

Publication number Publication date
DK1636344T3 (da) 2010-05-31
US7611885B2 (en) 2009-11-03
CN1809629A (zh) 2006-07-26
EP1636344B1 (de) 2010-03-17
ES2367535T3 (es) 2011-11-04
PT1947171E (pt) 2011-09-07
CN103361286B (zh) 2016-12-28
EP1636344A1 (de) 2006-03-22
HUE030642T2 (en) 2017-06-28
ES2342830T3 (es) 2010-07-15
DK1947171T3 (da) 2011-09-19
AU2004249970B2 (en) 2009-09-10
EP1947171B1 (de) 2011-06-15
ATE461269T1 (de) 2010-04-15
DK2333044T3 (en) 2016-12-12
SI2333044T1 (sl) 2016-12-30
US10076545B2 (en) 2018-09-18
HK1158261A1 (zh) 2012-07-13
CA2530055C (en) 2012-10-02
PL1947171T3 (pl) 2011-12-30
AU2009239519A1 (en) 2009-12-10
EP1947171A1 (de) 2008-07-23
JP4834544B2 (ja) 2011-12-14
CN1809629B (zh) 2013-06-12
NZ544653A (en) 2009-02-28
CA2530055A1 (en) 2004-12-29
ES2602572T3 (es) 2017-02-21
US20130236422A1 (en) 2013-09-12
HK1089207A1 (en) 2006-11-24
MXPA05013620A (es) 2006-02-24
CN103361286A (zh) 2013-10-23
AU2004249970A1 (en) 2004-12-29
JP2007520201A (ja) 2007-07-26
PL2333044T3 (pl) 2017-02-28
WO2004113507A9 (en) 2006-08-24
CY1118218T1 (el) 2017-06-28
WO2004113507A1 (en) 2004-12-29
US8003091B2 (en) 2011-08-23
AU2009239519B2 (en) 2010-04-22
US20040265994A1 (en) 2004-12-30
PT2333044T (pt) 2016-11-21
EP2333044B1 (de) 2016-08-17
EP1636344A4 (de) 2006-07-19
EP2333044A1 (de) 2011-06-15
DE602004026051D1 (de) 2010-04-29
US20110177185A1 (en) 2011-07-21
HK1121190A1 (en) 2009-04-17
US8449877B2 (en) 2013-05-28
CA2780843C (en) 2013-12-10
CA2780843A1 (en) 2012-08-13
US20070241067A1 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
CY1118218T1 (el) Φαρμακευτικα συμβατη μεθοδος για τον καθαρισμο αθικτων βακτηριακων μινι-κυτταρων
Gilbert et al. Useful proteins from recombinant bacteria
Garon et al. Structural features of Borrelia burgdorferi—the Lyme disease spirochete: silver staining for nucleic acids
DE60236145D1 (de) Zellisolierungsverfahren und verwendungen davon
JPS6391093A (ja) 高分子量dnaの迅速単離方法
AU6114199A (en) Isolation method for nucleic acid and apparatus
ATE204907T1 (de) Verfahren zur extraktion von polyhydroxy- alkanoaten aus diese enthaltenden halophilen bakterien
JP2002515508A (ja) 核酸の精製方法および装置
ATE530253T1 (de) Zusammensetzung, kit und verfahren zur zelltrennung
Brown et al. Chloroplast RNA populations in dark-grown, light-grown, and greening Euglena gracilis
HUT62311A (en) Process for separating dna
KR880701110A (ko) 생물학적 반응 모디파이어
WO2004048398A1 (ja) 核酸の濃縮精製方法および装置
Krusberg et al. Technique for axenizing nematodes
Allen Isolation of micronuclear and macronuclear DNA
SHIOMI et al. Metrizamide isopycnic centrifugation for the isolation of macro-and micronuclei from Paramecium
Kristiansen et al. Conservation of Active Ribosomes in Acetone‐Treated Cells of Tetrahymena pyriformis
AU2004238088B2 (en) Cell separation
Scheinman et al. Reconstitution of a minimal small ribosomal subunit
CN111440722A (zh) 一种自由流等电聚焦电泳微生物组分离制备的方法及应用
CN112983367A (zh) 一种弓形菌在微生物驱油现场试验效果评价中的应用及其方法
Holmqvist Disappearence of the intracytoplasmic membranes in Rhodopseudomonas sphaeroides: A quantitative ultrastructural study
Takigami et al. 2.9 Removal of Pollutants by Mutant Strains of Microorganisms Induced by Ion-Beam Irradiation Fixation of CO2 by Microalgae
DE69012903D1 (de) Verfahren zur herstellung und reinigung von hepatitis b-impfstoff.
KR970020168A (ko) 막을 통해 발효 브로쓰로부터 세포를 제거하는 방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1947171

Country of ref document: EP